Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
07/2003
07/02/2003EP1322307A1 Methods for treating cell proliferative disorders and viral infections
07/02/2003EP1322291A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
07/02/2003EP1322290A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight
07/02/2003EP1322288A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions
07/02/2003EP1322287A2 Microparticles for delivery of the heterologous nucleic acids
07/02/2003EP1227825A4 Isolation and expansion of human marrow stromal cells
07/02/2003EP1143994B1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto)immune diseases
07/02/2003EP0910246A4 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
07/02/2003EP0880530B1 Phosphatidyl oligoglycerols
07/02/2003EP0873491B1 Ceramic packing with channels for thermal and catalytic beds
07/02/2003EP0826043B1 Methods for modulating t cell survival by modulating bcl-xl protein level
07/02/2003EP0781343B1 Retroviral vector hybrids and the use thereof for gene transfer
07/02/2003EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
07/02/2003CN1427887A Pluripotent cells comprising allogenic nucleus and mitochondria
07/02/2003CN1427076A Combined deletion 19 Kda, 55KDA, E1B code sequence recombination adenovirus construction body and its use
07/02/2003CN1427075A Recombination adenovirus construction body with deletion E1A code sequence and its use
07/02/2003CN1427008A Method of designing and selecting natural siRNA as gene medicine and medicine formulation
07/02/2003CN1113099C New carrier for gene treatment
07/02/2003CN1112943C Gas driven gene delivery instrument
07/01/2003US6586582 Human GABA receptor proteins and polynucleotides encoding the same
07/01/2003US6586581 Prolactin regulatory element binding protein and uses thereof
07/01/2003US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics
07/01/2003US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein
07/01/2003US6586569 Endometriosis-associated gene
07/01/2003US6586524 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
07/01/2003US6586409 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
07/01/2003US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
07/01/2003US6586391 Method of ameliorating erectile dysfunction
07/01/2003US6586225 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging
07/01/2003US6586203 ARF-P19, a novel regulator of the mammalian cell cycle
07/01/2003US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a
07/01/2003US6586189 Screening method for PPAR-γ ligands
07/01/2003US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
07/01/2003US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides
07/01/2003US6586180 Directed antisense libraries
07/01/2003US6586003 Emulsion and micellar formulations for the delivery of biologically active substances to cells
07/01/2003US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
07/01/2003US6585968 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
06/2003
06/26/2003WO2003052121A2 Method of reducing angiogenesis
06/26/2003WO2003052117A2 Methods and products related to non-viral transfection
06/26/2003WO2003052095A2 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
06/26/2003WO2003052086A1 Immune related neuronal receptors and therapeutic uses thereof
06/26/2003WO2003052067A2 Vector mediated organelle transfection
06/26/2003WO2003052052A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof
06/26/2003WO2003051920A1 A method for inducing apoptosis
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003WO2003051911A2 Gmg-5 polynucleotides and polypeptides and uses thereof
06/26/2003WO2003051834A2 Immunocellular receptors related to neurological disorders
06/26/2003WO2003051454A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
06/26/2003WO2003051402A1 Adenoviral vector containing cyclooxygenase-2 promoter and uses thereof
06/26/2003WO2003051396A1 Treating vascular disease by inhibiting myeloid differentiation factor 88
06/26/2003WO2003051383A2 Use of hmgb proteins and nucleic acids that code therefor
06/26/2003WO2003051278A2 Nanoparticle delivery vehicle
06/26/2003WO2003051272A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION
06/26/2003WO2003051180A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
06/26/2003WO2003020223A3 A cancer treatment system
06/26/2003WO2003014153A8 Cellular virus receptors and methods of use.
06/26/2003WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension
06/26/2003WO2002072079A3 Modulators of the ank-pyrophosphate channel for use in osteoporosis therapy
06/26/2003WO2002070696A3 Cd109 nucleic acid molecules polypeptides and methods of use
06/26/2003WO2002064781A3 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002044406A3 Projection against mycobacterial infections
06/26/2003WO2002004493A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
06/26/2003WO2001090154A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
06/26/2003US20030121068 Vector encoding suicide and marker constructs
06/26/2003US20030121062 Transgenic organism
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030120039 Human preoptic regulatory factor-2 and uses thereof
06/26/2003US20030119900 Ureas, amides, and carbamates; dicyclohexyl urea
06/26/2003US20030119891 Polylactam oligomers of N-methyl-2-carboxy-4-imidazole, N-methyl-2-carboxy-4-aminopyrrole modified by 4-aminobutyric acid, 3-amino-propionic acid and 3-(dimethylamino)propylamine binding specifically to the cyclogenase 2 gene
06/26/2003US20030119778 Novel gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof
06/26/2003US20030119777 Oligoribonucleotides and ribonucleases for cleaving RNA
06/26/2003US20030119775 Treating a disease or disorder associated with diminished UCP2 expression or activity, such as obesity, diabetes, syndrome X, or hypothermia, by administering an agent that enhances UCP2 expression
06/26/2003US20030119772 Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
06/26/2003US20030119771 Especially inducers of osteoblast differentiation
06/26/2003US20030119770 Recombinant lentiviral vectors containing a therapeutic gene of interest fused in-frame with an intercellular trafficking gene for the global delivery of therapeutic proteins in nondividing cells.
06/26/2003US20030119769 Antisense oligonucleotide modulation of raf gene expression
06/26/2003US20030119766 Antisense modulation of apolipoprotein (A) expression
06/26/2003US20030119729 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030119192 Complementing cell lines
06/26/2003US20030119188 Novel compounds
06/26/2003US20030119187 Antigen presenting cells, method for their preparation and their use for cancer vaccines
06/26/2003US20030119182 Immunotherapy; genetic engineering; anticancer agents
06/26/2003US20030119168 Diagnosis of anticancer agents using nucleic acids
06/26/2003US20030119104 Genetic engineered artificial chromosomes in plants, animals
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119045 Controlling cell proliferation; adjust adhesion to substrate
06/26/2003US20030119041 Cloning Dna of target transcript; insertion of antibody gene; forming library
06/26/2003US20030119036 Isolated nucleic acids; anticholesterol agents, cardiovascular disorders, antiinflammatory agents, antilipemic agents
06/26/2003US20030119033 Immunoassay using antibodies
06/26/2003US20030119017 Anticancer agents, antiinflammatory agents, autoimmune disease; modulation of gene expression; nuclear factor kappa B
06/26/2003US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use
06/26/2003US20030119003 Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
06/26/2003US20030118993 Nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
06/26/2003US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 870